Global antimicrobial fund expands with USD 140m and CEO
The Wellcome Trust, the EIB and the Boehringer Ingelheim Foundation now financially support the work of the AMR Action Fund.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN
Less than a year after the AMR Action Fund addressing antimicrobial resistance was founded with financial support from the pharmaceutical industry, the fund has raised more capital.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Millions of vaccines waiting in warehouses
For subscribers
EMA clarifies: No Russian application for vaccine approval
For subscribers
.jpg&w=384&q=75)
